Osteoarthritis 2026-04-27 · 6 min

WOMAC: how to calculate and interpret the 3 subscales in osteoarthritis

Complete WOMAC LK 3.1 guide — inverted formula, 3 subscales, MCID and use in total knee and hip arthroplasty.

Ad space

What is the WOMAC?

The WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) was developed by Bellamy et al. (1988) as a patient-reported outcome instrument for patients with knee and hip osteoarthritis. It evaluates three domains — pain, stiffness and physical function — on a Likert scale of 0 (no symptoms) to 4 (extreme symptom).

It is the most validated instrument for monitoring outcomes in total knee and hip arthroplasty, and one of the most widely used in osteoarthritis clinical trials worldwide.

The 3 subscales (LK 3.1 version)

SubscaleItemsRaw maximumFocus
A — Painp1–p5 (5 items)20Pain at rest, stairs, at night, sitting, standing
B — Stiffnesss1–s2 (2 items)8Morning stiffness and after rest
C — Physical Functionf1–f17 (17 items)68Stairs, rising, walking, getting in/out car

Calculate the WOMAC for free

Apply the questionnaire online and get the score with exportable PDF.

Formula and score inversion

Formula per subscale — normalised and inverted version
Score = 100 − [(Raw sum / Subscale maximum) × 100]
100 = no symptoms  |  0 = worst possible state
Likert items: 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = extreme

There is no official composite score — each subscale is interpreted independently.

Ad space

Clinical interpretation

Score (inverted 0–100)InterpretationSuggested management
70–100Good functionPeriodic monitoring
40–69Moderate limitationConservative treatment, physiotherapy
0–39Significant limitationPriority specialist evaluation

Estimated MCID: 10–12 points for Physical Function; 8–10 points for Pain (Bellamy, 2002).

Use in total knee arthroplasty

TimepointExpected score (Physical Function)
Pre-operative35–50 pts
3 months post-TKA55–70 pts
6 months post-TKA65–80 pts
12 months post-TKA70–85 pts

The WOMAC is the most commonly used primary endpoint in total knee and hip arthroplasty studies, required by most national and international arthroplasty registries.

References

  1. 1. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. “Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.” J Rheumatol, 1988;15(12):1833–40.
  2. 2. Bellamy N. “WOMAC: a 20-year experiential review of a patient-centered self-reported health status questionnaire.” J Rheumatol, 2002;29(12):2473–6.